Clinical trial · Interventional
Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
Transcranial Direct Current Stimulation (tDCS) to Reduce Pain in Patients With Chemotherapy Induced Peripheral Neuropathy: A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Per PI termination request, no patients enrolled
Summary
Brief summary (as posted)
This early phase I trial studies how well transcranial direct current stimulation works in reducing pain in cancer patients with chemotherapy induced peripheral neuropathy. Transcranial direct current stimulation is used for patients with brain injuries such as strokes as well as for mental health issues such as depression and may help to control pain in cancer patients with chemotherapy induced peripheral neuropathy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy-Induced Peripheral Neuropathy | — | UNRESOLVED | — |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quality-of-Life Assessment | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Transcranial Direct Current Stimulation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive care (tDCS)
- description
- Patients undergo tDCS QD over 20 minutes 5 days each week (Monday-Friday) for 3 weeks.
- interventionNames
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
- Procedure: Transcranial Direct Current Stimulation
Primary outcomes (1)
- measure
- Change in chemotherapy induced peripheral neuropathy pain score
- timeFrame
- Baseline up to final day of treatment (3 weeks)
- description
- The Pain inventory is an assessment of pain level on a 11-point numeric rating scales (0=none to 10=worst).
Secondary outcomes (5)
- measure
- Change in total opioid requirement (morphine equivalent daily dosage)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion: * Age greater than or equal to 18 years. * Able to give a Voluntary written consent. * Cancer patients with chemotherapy induced peripheral neuropathy of at least 3 months duration.. * Pain and/or tingling of at least 4/10 Exclusion: * History of seizure * History of migraine headache * History of brain cancer and/or brain metastasis
References
Publications (0)
Data not yet available